We are a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs. Our vision is to contribute to a world where no one dies or suffers from a vaccine-preventable disease.

Valneva at a glance

Commercial vaccines

€m

Total revenues in 2023

Unique vaccine development programs

Integrated

differentiated clinical and pre-clinical assets

robust commercial portfolio

Focused

on prevention of infectious diseases with significant unmet medical need

~700

employees in six countries